Registries and Post-Marketing Data Collection
Washington, DC
FDA Post-Marketing Surveillance
David S. Buckles, PhD, FACC
Peripheral Vascular Devices Branch
Division of Cardiovascular Devices
Office of Device Evaluation
Registries-A Dubious Panacea or the Best Thing Since Sliced Bread?
David Chen, Ph.D.
Vice President Engineering / R&D Director
Medical Metrx Solutions
The OIG: The View from the Inside . . . and What's Ahead
Dara A. Corrigan
Partner
Arnold & Porter LLP
The HIPAA Privacy Rule: Implications for CMS Proposed "Coverage With Evidence" Data Collection
Nancy L. Perkins
Partner
Arnold & Porter LLP
"Safe and Effective" Is It Enough?
Stephen Phurrough, MD, MPA
Director, Coverage and Analysis Group
Centers for Medicare and Medicaid Services
Registries: Uses and Limitations
Charles Turkelson, Ph.D.
Chief Research Analyst, Health Technology Assessment Group, ECRI
Technical Director, ECRI/AHRQ Evidence-based Practice Center
Speech: The Future of Medicare in a Growing Fiscal Storm
Jim Turner
Partner
Arnold & Porter